Earnings History Data for Travere Therapeutics, Inc. (TVTX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Travere Therapeutics, Inc.
Travere Therapeutics Inc. is a biopharmaceutical company. It engages to identify, develop and deliver life-changing therapies. Travere Therapeutics Inc., formerly known as Retrophin Inc., is based in SAN DIEGO.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31-10-2024 | PM | TVTX | Travere Therapeutics, Inc. | 1,410 | -0.70 | -0.71 | -1.17 | Travere Therapeutics beats Q3 revenue estimates [10/31/2024 7:11 AM] |
17.55 | -0.20 (-1.15%) |
17.00 | -0.75 (-4.25%) |
5.12 - 19.25 | 1,122,510 | 1,120,000 | 21,227 | ||
|
||||||||||||||||||
| 01-08-2024 | AH | TVTX | Travere Therapeutics, Inc. | 723.23 | -0.90 | -0.87 | -1.13 | Travere Therapeutics Non-GAAP EPS of -$0.65 beats by $0.07, revenue of $54.12M beats by $1.43M [8/1/2024 5:36 PM] |
9.06 | -0.18 (-1.95%) |
9.23 | -0.01 (-0.11%) |
5.12 - 16.79 | 1,709,703 | 910,000 | 8,743 | ||
| 06-05-2024 | AH | TVTX | Travere Therapeutics, Inc. | 468.77 | -1.76 | -0.98 | -1.27 | Travere Therapeutics Non-GAAP EPS of $1.51 beats by $2.30, revenue of $41.37M misses by $2.25M [5/6/2024 4:04 PM] |
6.76 | 0.21 (3.21%) |
7.33 | 0.78 (11.91%) |
5.12 - 19.54 | 1,609,320 | 1,550,000 | 8,466 | ||
| 15-02-2024 | AH | TVTX | Travere Therapeutics, Inc. | 600.42 | -1.16 | -1.27 | -1.03 | Travere Therapeutics Non-GAAP EPS of $0.94 beats by $1.86, revenue of $45.05M beats by $3.23M [2/15/2024 4:05 PM] |
8.20 | -0.54 (-6.24%) |
8.85 | 0.11 (1.26%) |
5.25 - 23.18 | 1,050,402 | 960,000 | 2,223 | ||
| 07-11-2023 | AH | TVTX | Travere Therapeutics, Inc. | 522.83 | -1.17 | -1.09 | -1.09 | Travere Therapeutics Non-GAAP EPS of $2.27 beats by $2.23, revenue of $37.09M [11/7/2023 4:20 PM] |
6.34 | -0.83 (-11.63%) |
6.85 | -0.33 (-4.60%) |
6.31 - 23.18 | 1,664,111 | 1,870,000 | 17,094 | ||
| 03-08-2023 | AH | TVTX | Travere Therapeutics, Inc. | 1,250 | -1.13 | -1.16 | -1.05 | Travere Therapeutics GAAP EPS of -$1.13 beats by $0.03, revenue of $57M beats by $3.4M [8/3/2023 4:11 PM] |
15.48 | -0.80 (-4.88%) |
16.28 | 0.0 (0.00%) |
14.51 - 29.14 | 1,480,042 | 1,000,000 | 863,317 | ||
| 04-05-2023 | AH | 4:00 PM ET (May 4) |
TVTX | Travere Therapeutics, Inc. | 1,170 | -1.27 | -1.21 | -1.20 | Travere Therapeutics Non-GAAP EPS of -$0.82 beats by $0.25, revenue of $57M beats by $6.4M [5/4/2023 5:27 PM] |
16.78 | 0.81 (5.07%) |
16.31 | 0.34 (2.13%) |
14.51 - 29.14 | 1,865,906 | 2,140,000 | 754 | |
| 23-02-2023 | AH | 4:00 PM ET (Feb 23) |
TVTX | Travere Therapeutics, Inc. | 1,140 | -1.03 | -1.04 | -0.84 | Travere Therapeutics Non-GAAP EPS of -$0.76 beats by $0.08, revenue of $55.9M beats by $2.88M [2/23/2023 4:05 PM] |
22.29 | 0.41 (1.87%) |
21.78 | -0.10 (-0.46%) |
17.82 - 30.35 | 1,665,462 | 2,670,000 | 1,434 | |
| 27-10-2022 | AH | 4:00 PM ET (Oct 27) |
TVTX | Travere Therapeutics, Inc. | 1,430 | -1.09 | -0.97 | -0.59 | Travere Therapeutics GAAP EPS of -$1.09 misses by $0.17, revenue of $53.5M misses by $1.26M [10/27/2022 4:08 PM] |
22.93 | 0.45 (2.00%) |
22.48 | 0.0 (0.00%) |
20.48 - 31.65 | 502,866 | 1,240,000 | 88,050 | |
|
||||||||||||||||||
| 04-08-2022 | PM | Before the open (Aug 4) |
TVTX | Travere Therapeutics, Inc. | 1,490 | -1.05 | -0.94 | -0.64 | Travere Therapeutics GAAP EPS of -$1.05 misses by $0.14, revenue of $54.2M beats by $4.7M [8/4/2022 7:21 AM] |
25.72 | 1.72 (7.17%) |
22.00 | -2.00 (-8.33%) |
13.61 - 31.65 | 2,157,389 | 720,000 | 33,011 | |
| 05-05-2022 | AH | 4:00 PM ET (May 5) |
TVTX | Travere Therapeutics, Inc. | 1,630 | -1.20 | -0.85 | -0.96 | Travere Therapeutics Non-GAAP EPS of $0.82 beats by $1.55, revenue of $48.5M misses by $3.42M [5/5/2022 4:27 PM] |
22.24 | -2.35 (-9.56%) |
22.24 | 0.0 (0.00%) |
12.75 - 31.65 | 1,144,699 | 610,000 | 2,348 | |
| 24-02-2022 | AH | 4:00 PM ET (Feb 24) |
TVTX | Travere Therapeutics, Inc. | 1,710 | -0.84 | -0.72 | -2.37 | Travere Therapeutics Non-GAAP EPS of -$0.61 misses by $0.11, revenue of $57.25M beats by $0.85M [2/24/2022 4:15 PM] |
26.66 | -0.50 (-1.84%) |
27.16 | 0.0 (0.00%) |
12.75 - 31.65 | 181,663 | 640,000 | 505,155 | |
| 28-10-2021 | AH | 4:00 PM ET (Oct 28) |
TVTX | Travere Therapeutics, Inc. | 1,620 | -0.59 | -0.72 | -0.44 | Travere Therapeutics EPS beats by $0.35, beats on revenue [10/28/2021 4:04 PM] |
28.87 | 2.28 (8.57%) |
26.00 | -0.59 (-2.22%) |
12.75 - 33.09 | 809,742 | 400,000 | 12,128 | |
| 29-07-2021 | AH | 4:00 PM ET (Jul 29) |
TVTX | Travere Therapeutics, Inc. | 799.85 | -0.64 | -0.73 | -0.58 | Travere Therapeutics EPS beats by $0.11, beats on revenue [7/29/2021 4:43 PM] |
13.74 | -0.10 (-0.72%) |
13.85 | 0.01 (0.07%) |
12.75 - 33.09 | 306,707 | 500,000 | 102 | |
| 06-05-2021 | AH | 4:00 PM ET (May 6) |
TVTX | Travere Therapeutics, Inc. | 1,500 | -0.96 | -0.56 | 0.02 | Travere Therapeutics EPS misses by $0.25, misses on revenue [5/6/2021 4:36 PM] |
20.01 | -3.49 (-14.85%) |
22.16 | -1.34 (-5.70%) |
14.50 - 33.09 | 2,220,610 | 360,000 | 616 | |
| 01-03-2021 | AH | After the close (Mar 1) |
TVTX | Travere Therapeutics, Inc. | 1,600 | -2.37 | -0.43 | -0.70 | Travere Therapeutics EPS misses by $1.99, misses on revenue [3/1/2021 4:23 PM] |
29.34 | -1.23 (-4.01%) |
29.11 | -1.45 (-4.74%) |
8.98 - 33.09 | 502,981 | 667,960 | 2,186 | |